Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.
Abstract: In adversarial environments, unmanned aerial vehicle (UAV) swarms often face challenges such as node failures, battle damage, and strong electromagnetic interference, which may result in ...
Abstract: In recent years, the spotlight of research in the adaptive learning era has turned toward distributed adaptive filtering algorithms for sparse systems over ...